Skip to main content
Contact Us
Subscribe
E-Edition
60°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about CERE
Recent news which mentions CERE
< Previous
1
2
3
4
Next >
Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
April 18, 2024
Tickers
ABBV
CERE
NEWS
Tags
ABBV
Top Stories
Biotech
From
Benzinga
Why Is Ulcerative Colitis-Focused Landos Biopharma Stock Trading Higher On Monday?
March 25, 2024
Tickers
ABBV
CERE
LABP
NEWS
Tags
ABBV
LABP
Market News
From
Benzinga
3 Unstoppable Mega-Cap Stocks That Every Investor Should Own in 2024
March 09, 2024
Tickers
ABBV
CERE
CRM
IMGN
Tags
NASDAQ:NVDA,NYSE:ABBV,NYSE:CRM,NASDAQ:IMGN,NASDAQ:CERE
IMGN
Market News
From
InvestorPlace
Is AbbVie Stock a Buy Now?
February 22, 2024
Tickers
ABBV
CERE
Tags
Recent Press Releases
ABBV
Market News
From
Motley Fool
This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space
February 16, 2024
Tickers
BHVN
CERE
KRTX
NEWS
Tags
News
Briefs
KRTX
From
Benzinga
UBS Bullish On This Depression Drug Maker, Says Alzheimer's Agitation Data Is Attractive Catalyst
February 06, 2024
Tickers
ABBV
AXSM
BMY
CERE
Tags
ABBV
Trading Ideas
Analyst Color
From
Benzinga
AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall
February 02, 2024
Tickers
ABBV
CERE
IMGN
NEWS
Tags
CERE
Movers
Benzinga
From
Benzinga
AbbVie's Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures
January 29, 2024
Tickers
ABBV
CERE
IMGN
NEWS
Tags
Trading Ideas
Analyst Color
ABBV
From
Benzinga
7 Dividend Aristocrats That Will Pay You for Years to Come
January 22, 2024
Tickers
ABBV
ALB
APD
ATO
Tags
LEG
Stocks to Buy
SBUX
From
InvestorPlace
5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
January 08, 2024
Tickers
ABBV
AMGN
BMY
CERE
Tags
ABBV
VRTX
JPMoragn
From
Benzinga
Is AbbVie Stock a Buy Now?
January 07, 2024
Tickers
ABBV
CERE
IMGN
Tags
CERE
Market News
Recent Press Releases
From
Motley Fool
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
Tickers
ABBV
ALPMY
BIIB
BMED
Tags
M&A
Health Care
PINK
From
Benzinga
JP Morgan Maintains Neutral Rating for Cerevel Therapeutics Hldg: Here's What You Need To Know
December 28, 2023
Tickers
CERE
Tags
Benzinga
Analyst Ratings
CERE
From
Benzinga
Tesla To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Friday
December 22, 2023
Tickers
ALPN
CCL
CERE
CFG
Tags
CTAS
DUK
News
From
Benzinga
The 7 Most Undervalued Growth Stocks to Buy in December
December 13, 2023
Tickers
ABBV
BA
C
CERE
Tags
IMGN
Market News
F
From
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
December 11, 2023
Tickers
BLUE
CERE
CI
CVS
Tags
CVS
CI
CERE
From
Benzinga
The 3 Best Cheap Stocks to Buy in December
December 10, 2023
Tickers
ABBV
CERE
CVX
DELL
Tags
NYSE:ABBV,NYSE:DELL,NYSE:CVX,NYSE:HES,NASDAQ:CERE,NASDAQ:IMGN
HES
Market News
From
InvestorPlace
4 Top Dividend Stocks Yielding More Than 4% to Buy Hand-Over-Fist This December
December 10, 2023
Tickers
ABBV
BEP
BEPC
CERE
Tags
VZ
Recent Press Releases
Market News
From
Motley Fool
AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?
December 10, 2023
Tickers
ABBV
CERE
IMGN
Tags
IMGN
ABBV
Recent Press Releases
From
Motley Fool
AbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?
December 08, 2023
Tickers
ABBV
CERE
IMGN
Tags
CERE
Recent Press Releases
Market News
From
Motley Fool
AbbVie's New $9B Neuroscience Space Deal Might Attract FTC Scrutiny, Analyst Signals
December 07, 2023
Tickers
ABBV
CERE
IMGN
Tags
Expert Ideas
M&A
Health Care
From
Benzinga
Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 07, 2023
Tickers
AAMC
ABBV
AGX
AI
Tags
FLJ
JBLU
Market News
From
Benzinga
Why Cerevel Therapeutics Stock Is Higher
December 07, 2023
Tickers
ABBV
CERE
Tags
General
News
ABBV
From
Benzinga
Why Is Cyngn (CYN) Stock Up 73% Today?
December 07, 2023
Tickers
CERE
CYN
LILM
NKLA
Tags
NASDAQ:CYN,NASDAQ:LILM,NASDAQ:NKLA,NASDAQ:CERE
Market News
NKLA
From
InvestorPlace
Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday
December 07, 2023
Tickers
ABBV
ALT
ASLE
BASE
Tags
CERE
Benzinga
News
From
Benzinga
LILM Stock Alert: Lilium Partners Up With Lufthansa
December 07, 2023
Tickers
CERE
FSR
LILM
NKLA
Tags
Today's Market
FSR
LILM
From
InvestorPlace
Why Is Cerevel Therapeutics (CERE) Stock Up 12% Today?
December 07, 2023
Tickers
ABBV
CERE
Tags
ABBV
NASDAQ:CERE,NYSE:ABBV
Market News
From
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 07, 2023
Tickers
ANIX
ATRA
CERE
DARE
Tags
VNDA
LSDI
BZI/TFM
From
Benzinga
Why Cerevel Therapeutics Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
December 07, 2023
Tickers
AAMC
ABBV
ASLE
BETS
Tags
CHWY
Premarket Movers
Market News
From
Benzinga
Datadog To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Thursday
December 07, 2023
Tickers
AVAV
BRZE
CERE
DDOG
Tags
FEAM
News
SMTC
From
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.